Laboratory results of the 94 pwSCD for whom clinical data were available before and after the initial SCD-pulmonary visit
| Characteristic (median, IQR) . | Before . | After . | P value . |
|---|---|---|---|
| WBCs (103/μL) | 10.8 (8.4-13.2) | 9.2 (7.0-12.2) | .0105 |
| Hemoglobin (g/dL) | 9.5 (7.8-10.8) | 9.6 (8.3-10.9) | .0260 |
| Platelets (103/μL) | 343 (251-446) | 378 (243-475) | .16 |
| Reticulocyte (%) | 7.5 (3.5-14.2) | 6.1 (3.5-12.7) | .77 |
| RBCs (106/μL) | 3.2 (2.7-4.2) | 3.0 (2.6-4.0) | .0099 |
| MCV (fL) | 79.1 (71.8-85.0) | 83.5 (74.2-91.0) | <.0001 |
| ANC (103/mm3) | 4.5 (3.3-5.9) | 4.6 (3.1-5.6) | .62 |
| LDH (U/L) | 1011 (841-1251) | 780 (607-1026) | .0077 |
| Creatinine (mg/dL) | 0.37 (0.30-0.44) | 0.43 (0.35-0.51) | <.0001 |
| Hemoglobin F (%) | 18.5 (12.7-32.4) | 17.6 (9.2-23.4) | .0059 |
| Characteristic (median, IQR) . | Before . | After . | P value . |
|---|---|---|---|
| WBCs (103/μL) | 10.8 (8.4-13.2) | 9.2 (7.0-12.2) | .0105 |
| Hemoglobin (g/dL) | 9.5 (7.8-10.8) | 9.6 (8.3-10.9) | .0260 |
| Platelets (103/μL) | 343 (251-446) | 378 (243-475) | .16 |
| Reticulocyte (%) | 7.5 (3.5-14.2) | 6.1 (3.5-12.7) | .77 |
| RBCs (106/μL) | 3.2 (2.7-4.2) | 3.0 (2.6-4.0) | .0099 |
| MCV (fL) | 79.1 (71.8-85.0) | 83.5 (74.2-91.0) | <.0001 |
| ANC (103/mm3) | 4.5 (3.3-5.9) | 4.6 (3.1-5.6) | .62 |
| LDH (U/L) | 1011 (841-1251) | 780 (607-1026) | .0077 |
| Creatinine (mg/dL) | 0.37 (0.30-0.44) | 0.43 (0.35-0.51) | <.0001 |
| Hemoglobin F (%) | 18.5 (12.7-32.4) | 17.6 (9.2-23.4) | .0059 |
Data represented as median (IQR). P values result from Wilcoxon signed rank test.
ANC, absolute neutrophil count; LDH, lactate dehydrogenase; RBCs, red blood cells; WBCs, white blood cells.